Platelet-to-neutrophil ratio predicts hemorrhagic transformation and unfavorable outcomes in acute ischemic stroke with intravenous thrombolysis

Table 2 Clinical characteristics of the study population (continued)

Characteristics	Number
Baseline blood glucose in mg%	110 (96-141)
Laboratory tests
Hb	13.3 (12.2-14.4)
WBC as 109/L	8.4 (6.81-10.51)
Platelets as 109/L	227 (192-278)
Neutrophil as 109/L	5.14 (3.8-7.06)
Lymphocyte as 109/L	1.93 (1.36-2.7)
P/NR	43.73 (32.0-59.04)
PLR	115.33 (87.17-170.64)
NLR	2.56 (1.61-4.52)
PWR	27.07 (21.4-33.99)
LDL	114.5 (89-143)
NIHSS on admission	10 (6-16)
NIHSS score on discharge date (day 1-7)	5 (1-10)
Outcome events
Increase NIHSS from baseline or death within 7 d after IV rt-PA
Poor outcome (≥ 4 score)	24 (5.7)
Good outcome (< 4 score)	394 (94.3)
mRS on admission	5 (3.75-5)
Poor outcome (3-6)	348 (83.3)
Good outcome (0-2)	70 (16.7)
mRS on discharge date (day 1-7)	3 (1-4)
Poor outcome (3-6)	236 (56.5)
Good outcome (0-2)	182 (43.5)
mRS at 3 mo	2 (0-4)
Poor outcome (3-6)	168 (40.2)
Good outcome (0-2)	250 (59.8)

Data are n (%)/median (25^th-75^th percentiles). Hb: Hemoglobin; LDL: Low density lipoprotein; mRS: Modified Rankin Scale; NIHSS: National Institute of Health Stroke Scale; NLR: Neutrophil-to-lymphocyte ratio; P/NR: Platelet-to-neutrophil ratio; PLR: Platelet-to-lymphocyte ratio; WBC: White blood cell.